Moviprep and Mesalamine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Moviprep (ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate) and Mesalamine (mesalamine). Common drug interactions include anaemia among females and abdominal pain upper among males.

The phase IV clinical study analyzes what interactions people have when they take Moviprep and Mesalamine. It is created by eHealthMe based on reports of 78 people who take the same drugs from the FDA, and is updated regularly.

What is Moviprep?

Moviprep has active ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate. It is often used in colonoscopy abnormal. eHealthMe is studying from 3,173 Moviprep users. Check the latest studies of Moviprep.

What is Mesalamine?

Mesalamine has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 28,053 Mesalamine users. Check the latest studies of Mesalamine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

78 people who take Moviprep and Mesalamine together, and have interactions are studied.

Moviprep and Mesalamine drug interactions.

What are the common drug interactions of Moviprep and Mesalamine, by gender? *:

female:

Anaemia (lack of blood)
Constipation
Erythema (redness of the skin)
Female genital tract fistula (passage in genital tract of female)
Frequent bowel movements
Haematochezia (passage of stools containing blood)
Rectal haemorrhage (bleeding from anus)
Oral candidiasis (fungal infection of mouth)
Proctitis (inflammation of the rectum and anus)
Vaginal discharge

male:

Abdominal pain upper
Asthenia (weakness)
Tremor (trembling or shaking movements in one or more parts of your body)
Vomiting
Abdominal distension
Activated partial thromboplastin time prolonged
Anaemia (lack of blood)
Analgesic therapy
Antacid therapy
Anticoagulant therapy

What are the common drug interactions of Moviprep and Mesalamine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Cholangitis sclerosing (infection and obstruction of bile duct)
Drug ineffective
Fatigue (feeling of tiredness)
Fluid retention (an abnormal accumulation of fluid in the blood)
Headache (pain in head)
Hepatotoxicity (chemical-driven liver damage)
Insomnia (sleeplessness)
Liver disorder (liver diseases)
Nasopharyngitis (inflammation of the nasopharynx)
Skin disorder (skin disease)

30-39:

Acne (skin problems that cause pimples)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cholangitis sclerosing (infection and obstruction of bile duct)
Drug ineffective
Fatigue (feeling of tiredness)
Flatulence (flatus expelled through the anus)
Fluid retention (an abnormal accumulation of fluid in the blood)
Headache (pain in head)
Hepatotoxicity (chemical-driven liver damage)
Insomnia (sleeplessness)

40-49:

Anxiety
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Emotional distress
Fear
Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Pain
Psychological trauma
Pulmonary embolism (blockage of the main artery of the lung)

50-59:

Fatigue (feeling of tiredness)
Flatulence (flatus expelled through the anus)
Gastrointestinal motility disorder (abnormal intestinal contractions)
Headache (pain in head)
Hypoaesthesia (reduced sense of touch or sensation)
Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
Injection site haematoma (localized swelling filled with blood at injection site)
Injection site pain
Insomnia (sleeplessness)
Mucous membrane disorder (disease of mucous membrane)

60+:

Drug ineffective
Nausea (feeling of having an urge to vomit)
Malaise (a feeling of general discomfort or uneasiness)
Procedural pain
Anaemia (lack of blood)
Constipation
Headache (pain in head)
Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly)
Abdominal pain
Erythema (redness of the skin)

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 58 people, 74.36%
Allergies: 44 people, 56.41%
Colitis (inflammation of colon): 18 people, 23.08%
Fever: 9 people, 11.54%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 8 people, 10.26%
Nausea (feeling of having an urge to vomit): 7 people, 8.97%
Urethral Disorder: 4 people, 5.13%
Asthma: 4 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Moviprep and Mesalamine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously